Article references (20 references )


  1. Bingen E, Levy C, Varon E et al. Méningites à pneumocoque: impact du vaccin antipneumococcique heptavalent conjugué. Arch Pédiatrie. 2008; 15(5):543-4.

  2. Word Health Organization. Weekly Epidemiological Record, 1 December 2017, 92(48):729-748. October 2017. Accessed on 17 Jan 2019.

  3. Kayemba-Kay's S, Badran AM, Lagneaux C et al. Streptococcus pneumoniae serotype 19A meningitis in well-vaccinated immunocompetent 13-month-old child: a case of PCV13 failure. Clin Case Rep. 2016;4(11):1023-5. Google Scholar

  4. Diawara I, Zerouali K, Elmdaghri N et al. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine. BMC Pediatr. 2017; 17(1):114. PubMed | Google Scholar

  5. Elmdaghri N, Benbachir M, Belabbes H et al. Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco). Vaccine. 2012; 30 (Suppl 6):G46-50. PubMed | Google Scholar

  6. Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2010; 59(RR-11):1-18. PubMed | Google Scholar

  7. Moore CE, Paul J, Foster D et al. Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England. J Infect Dis. 2014; 210(7):1001-11. PubMed | Google Scholar

  8. Harboe ZB, Valentiner-Branth P, Ingels H et al. Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark. PLOS ONE. 2013; 8(1):e51460. PubMed | Google Scholar

  9. Godot C, Levy C, Varon E et al. Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France. Pediatr Infect Dis J. 2015; 34(10):e260-263. PubMed | Google Scholar

  10. Diawara I, Zerouali K, Katfy K et al. Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2015; 40:95-101. PubMed | Google Scholar

  11. Lepoutre A, Varon E, Georges S et al. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Vaccine. 2015; 33(2):359-66. PubMed | Google Scholar

  12. Hon KL, Ip M, Lee K et al. Childhood pneumococcal diseases and serotypes: can vaccines protect? Indian J Pediatr. 2010; 77(12):1387-91. PubMed | Google Scholar

  13. Joye S, Gao A, Kayemba-Kay's S et al. Invasive pneumococcal infection despite 7-valent conjugated vaccine. Clin Pract. 2013; 3(1):e11. PubMed | Google Scholar

  14. Grant LR, O'Brien SE, Burbidge P et al. Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes. PloS One. 2013; 8(9):e74906. PubMed | Google Scholar

  15. Bouskraoui M, Soraa N, Zahlane K et al. Étude du portage rhinopharyngé de Streptococcus pneumoniae et de sa sensibilité aux antibiotiques chez les enfants en bonne santé âgés de moins de 2 ans dans la région de Marrakech (Maroc). Arch Pédiatrie. 2011; 18(12):1265-70. Google Scholar

  16. Revilla F, OPAS/OMS. Reports of the Technical Advisory Group (TAG) on Vaccine-preventable Diseases. Pan Am Health Organization. 10 July 2018. Accessed on 16 Jan 2019

  17. Oliveira LH de, Camacho LAB, Coutinho ESF et al. Impact and Effectiveness of 10 and 13-Valent Pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 Years in Latin American Countries: a Systematic Review. PLOS ONE. 2016; 11(12):e0166736. Google Scholar

  18. Word Health Organization. SAGE meeting of October 2017. 17-19 October 2017. Accessed on 17 Jan 2019.

  19. Organisation Mondiale de la Santé. Relevé épidémiologique hebdomadaire (REH). 6 avril 2012; 87(14):129-144. Accessed on 16 Jan 2019.

  20. Palmu AA, Jokinen J, Borys D et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet Lond Engl. 2013; 381(9862):214-22. PubMed | Google Scholar